Literature DB >> 18470716

Procalcitonin in pediatrics for differentiation of bacterial and viral infections.

D Gendrel1, C Bohuon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 18470716     DOI: 10.1007/BF02900734

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  6 in total

1.  Measurement of procalcitonin levels in children with bacterial or viral meningitis.

Authors:  D Gendrel; J Raymond; M Assicot; F Moulin; J L Iniguez; P Lebon; C Bohuon
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

2.  Procalcitonin and C-reactive protein levels in neonatal infections.

Authors:  G Monneret; J M Labaune; C Isaac; F Bienvenu; G Putet; J Bienvenu
Journal:  Acta Paediatr       Date:  1997-02       Impact factor: 2.299

3.  Procalcitonin as a marker for the early diagnosis of neonatal infection.

Authors:  D Gendrel; M Assicot; J Raymond; F Moulin; C Francoual; J Badoual; C Bohuon
Journal:  J Pediatr       Date:  1996-04       Impact factor: 4.406

4.  Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates.

Authors:  C Chiesa; A Panero; N Rossi; M Stegagno; M De Giusti; J F Osborn; L Pacifico
Journal:  Clin Infect Dis       Date:  1998-03       Impact factor: 9.079

5.  Procalcitonin is a marker of severity of renal lesions in pyelonephritis.

Authors:  N Benador; C A Siegrist; D Gendrel; C Greder; D Benador; M Assicot; C Bohuon; E Girardin
Journal:  Pediatrics       Date:  1998-12       Impact factor: 7.124

6.  High serum procalcitonin concentrations in patients with sepsis and infection.

Authors:  M Assicot; D Gendrel; H Carsin; J Raymond; J Guilbaud; C Bohuon
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

  6 in total
  8 in total

Review 1.  Immune regulation of procalcitonin: a biomarker and mediator of infection.

Authors:  G N Matwiyoff; J D Prahl; R J Miller; J J Carmichael; D E Amundson; G Seda; M Daheshia
Journal:  Inflamm Res       Date:  2012-02-22       Impact factor: 4.575

Review 2.  Management of the non-toxic-appearing acutely febrile child: a 21st century approach.

Authors:  Ravi Jhaveri; Carrie L Byington; Jerome O Klein; Eugene D Shapiro
Journal:  J Pediatr       Date:  2011-05-17       Impact factor: 4.406

3.  Secretory phospholipase A2: a marker of infection in febrile children presenting to a pediatric ED.

Authors:  Karim M Mansour; Frans A Kuypers; Tammy N Wang; Annabeth M Miller; Sandra K Larkin; Claudia R Morris
Journal:  Am J Emerg Med       Date:  2010-08-13       Impact factor: 2.469

4.  Evaluation of serum procalcitonin levels for diagnosis of secondary bacterial infections in visceral leishmaniasis patients.

Authors:  Neda Pasyar; Abdolvahab Alborzi; Gholam R Pouladfar
Journal:  Am J Trop Med Hyg       Date:  2012-01       Impact factor: 2.345

5.  The behavior and diagnostic utility of procalcitonin and five other inflammatory molecules in critically ill patients with respiratory distress and suspected 2009 influenza a H1N1 infection.

Authors:  Mariana Benevides Santos Paiva; Fernando Antônio Botoni; Antônio Lúcio Teixeira; Aline Silva de Miranda; Clara Rodrigues Alves de Oliveira; Jamila de Oliveira Abrahão; Guilherme Marques Faria; Vandack Nobre
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

6.  Serum Procalcitonin is a sensitive and specific marker in the diagnosis of septic arthritis and acute osteomyelitis.

Authors:  Karthikeyan Maharajan; Dilip Kumar Patro; Jagdish Menon; Ananthanarayanan Palghat Hariharan; Sabhash Chandra Parija; Murali Poduval; Sreenivas Thimmaiah
Journal:  J Orthop Surg Res       Date:  2013-07-04       Impact factor: 2.359

7.  Procalcitonin as an indicator of urosepsis.

Authors:  Koichi Sugimoto; Shogo Adomi; Hiroyuki Koike; Atsunobu Esa
Journal:  Res Rep Urol       Date:  2013-03-26

8.  Procalcitonin as a useful marker to decide upon intervention for urinary tract infection.

Authors:  Koichi Sugimoto; Nobutaka Shimizu; Naoki Matsumura; Takashi Oki; Kazuhiro Nose; Tsukasa Nishioka; Hirotsugu Uemura
Journal:  Infect Drug Resist       Date:  2013-08-07       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.